Ramm Pharma Corp Stock Current Liabilities
RAMMFDelisted Stock | USD 0.06 0.00 0.00% |
RAMM Pharma Corp fundamentals help investors to digest information that contributes to RAMM Pharma's financial success or failures. It also enables traders to predict the movement of RAMM Pink Sheet. The fundamental analysis module provides a way to measure RAMM Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RAMM Pharma pink sheet.
RAMM |
RAMM Pharma Corp Company Current Liabilities Analysis
RAMM Pharma's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, RAMM Pharma Corp has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
All Next | Launch Module |
RAMM Fundamentals
Return On Equity | -0.12 | |||
Return On Asset | -0.0789 | |||
Profit Margin | (1.76) % | |||
Operating Margin | (1.89) % | |||
Current Valuation | 1.85 M | |||
Shares Outstanding | 122.4 M | |||
Shares Owned By Insiders | 34.88 % | |||
Shares Owned By Institutions | 0.89 % | |||
Price To Book | 0.18 X | |||
Price To Sales | 4.04 X | |||
Revenue | 4.12 M | |||
Gross Profit | (37.32 K) | |||
EBITDA | (6.36 M) | |||
Net Income | (7.11 M) | |||
Cash And Equivalents | 12.79 M | |||
Cash Per Share | 0.10 X | |||
Total Debt | 8.69 K | |||
Current Ratio | 9.18 X | |||
Book Value Per Share | 0.41 X | |||
Cash Flow From Operations | (3.82 M) | |||
Earnings Per Share | (0.05) X | |||
Beta | -0.75 | |||
Market Capitalization | 15.16 M | |||
Total Asset | 59.71 M | |||
Net Asset | 59.71 M |
About RAMM Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RAMM Pharma Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAMM Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAMM Pharma Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |